These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9120995)

  • 1. [Apo(a) phenotype as a risk factor for the silent brain infarction].
    Notsu Y; Nabika T; Masuda J; Kobayashi S
    Rinsho Byori; 1997 Feb; 45(2):122-6. PubMed ID: 9120995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) and other risk factors for cerebral infarction.
    Konemori G
    Hiroshima J Med Sci; 1995 Sep; 44(3):65-77. PubMed ID: 8567315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apolipoprotein(a) and cortical cerebral infarction].
    Zhang Y; Liang X
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):350-3. PubMed ID: 10923438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia.
    Emanuele E; Peros E; Tomaino C; Feudatari E; Bernardi L; Binetti G; Maletta R; Micieli G; Bruni AC; Geroldi D
    Dement Geriatr Cogn Disord; 2004; 18(2):189-96. PubMed ID: 15211075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apo(a) size in ischemic stroke: relation with subtype and severity on hospital admission.
    Zambrelli E; Emanuele E; Marcheselli S; Montagna L; Geroldi D; Micieli G
    Neurology; 2005 Apr; 64(8):1366-70. PubMed ID: 15851724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
    Liu X; Sun L; Li Z; Gao Y; Hui R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Montagna L; Falcone C; Geroldi D
    Clin Chim Acta; 2004 Dec; 350(1-2):159-65. PubMed ID: 15530473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein (a) phenotypes in cardio-cerebrovascular diseases.
    Zhuang YY; Li JJ; Wang JJ
    Chin Med J (Engl); 1994 Feb; 107(2):133-6. PubMed ID: 8194380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein(a) and cortical cerebral infarction.
    Yingdong Z; Xiuling L
    Chin Med Sci J; 1999 Dec; 14(4):249-54. PubMed ID: 12894903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Sumbuloglu V; Ekem S; Bozdogan S; Baris S; Aciman E; Cabuk F
    J Neurol Sci; 2009 Feb; 277(1-2):17-21. PubMed ID: 18945448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Geroldi D; Finardi G
    Cardiologia; 1999 Apr; 44(4):347-54. PubMed ID: 10371786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different risk factor profiles between silent brain infarction and symptomatic lacunar infarction.
    Kim MH; Moon JS; Park SY; An SA; Kim OJ; Kim NK; Oh SH
    Eur Neurol; 2011; 65(5):250-6. PubMed ID: 21464570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.
    Xiong ZW; Wahlqvist ML; Ibiebele TI; Biegler BM; Balazs ND; Xiong DW; Lim YL
    Clin Biochem; 2004 Apr; 37(4):305-11. PubMed ID: 15003733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus.
    Shi H; Fang J; Yang X; Shen Z; Zhu X
    Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency distribution of apoprotein(a) isoforms in patients with diabetes mellitus and healthy subjects.
    Labudović DD; Toseska KN; Alabakovska SB; Dimitrovski C; Jurhar M; Isjanovska R; Spiroski M; Todorova BB
    Croat Med J; 2003 Aug; 44(4):435-40. PubMed ID: 12950147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy as an indicator of silent brain infarction in asymptomatic hypertensive subjects.
    Kwon HM; Kim BJ; Oh JY; Kim SJ; Lee SH; Oh BH; Yoon BW
    J Neurol Sci; 2007 Jan; 252(2):159-62. PubMed ID: 17182058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
    Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
    J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of genetic risk factors for silent brain infarction.
    Notsu Y; Nabika T; Park HY; Masuda J; Kobayashi S
    Stroke; 1999 Sep; 30(9):1881-6. PubMed ID: 10471440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoprotein(a) and Apo-A isoforms in patients with intermittent claudication].
    Britareva VV; Afanas'eva OI; Dobrovol'skiĭ AB; Ezhov MV; Titaeva EV; Karpov IuA; Pokrovskiĭ SN
    Ter Arkh; 2002; 74(12):49-52. PubMed ID: 12577841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.